Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

10.07

-0.20 (-1.95%)

At close: Oct 19, 2026, 4:00 PM EDT

10.07

0.00 (0.00%)

After-hours: Oct 19, 2026, 7:00 PM EDT

Ginkgo Bioworks Holdings Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	132.42	170.16	227.04	251.46	477.71	313.84
Revenue Growth	-37.02%	-25.06%	-9.71%	-47.36%	52.22%	309.40%
Gross Profit	90.1	123.18	182.5	197.45	273.49	184.15
Operating Income	-297.06	-308.11	-478.72	-733.83	-2,196	-1,828
Net Income	-290.8	-312.76	-547.03	-892.87	-2,105	-1,830
Earnings Per Share	-4.96	-5.64	-10.54	-18.37	-50.20	-55.53
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cell Engineering	95.01	132.75	173.97	143.53	143.67	112.99
Biosecurity Service	24.53	37.41	53.07	78.98	298.59	177.81
Revenue (Total)	111.86	170.16	227.04	251.46	477.71	313.84

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	302.16	422.62	561.57	944.07	1,316	1,550
Total Debt	404.11	439.89	467.73	239.31	442.59	23.03
Net Cash (Debt)	-101.95	-17.27	93.84	704.76	873.2	1,527
Net Cash Growth	-	-	-86.69%	-19.29%	-42.81%	319.73%
Net Cash Per Share	-1.74	-0.31	1.81	14.50	20.79	44.90

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-170.24	-171.06	-319.59	-295.5	-252.2	-253.82
Capital Expenditures	-4.56	-7.67	-62.54	-40.8	-52.27	-56.52
Free Cash Flow	-174.8	-178.72	-382.13	-336.3	-304.47	-310.34
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	68.04%	72.39%	80.38%	78.52%	57.25%	58.68%
Operating Margin	-224.33%	-181.08%	-210.85%	-291.84%	-459.70%	-582.62%
Pretax Margin	-234.28%	-184.30%	-241.15%	-355.11%	-444.08%	-585.69%
Profit Margin	-219.61%	-183.81%	-240.94%	-355.08%	-440.63%	-583.12%
FCF Margin	-132.00%	-105.04%	-168.31%	-133.74%	-63.74%	-98.89%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	5.12	2.78	2.30	13.26	5.98	39.37